The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.)
Open accessAbstract
BACKGROUND: α-amylase and α-glucosidase digest the carbohydrates and increase the postprandial glucose level in diabetic patients. Inhibiting the activity of these two enzymes can control postprandial hyperglycemia, and reduce the risk of developing diabetes. Bitter gourd or balsam pear is one of the important medicinal plants used for controlling postprandial hyperglycemia in diabetes patients. However, there is limited information available on the presence of α-amylase and α-glucosidase inhibiting compounds. In the current study, the protein extracts from the fruits of M. charantia var. charantia (MCC) and M. charantia var. muricata (MCM) were tested for α-amylase and α-glucosidase inhibiting activities in vitro, and glucose lowering activity after oral administration in vivo. RESULTS: The protein extract from both MCC and MCM inhibited the activity of α-amylase and α-glucosidase through competitive inhibition, which was on par with Acarbose as indicated by in vitro percentage of inhibition (66 to 69 %) and IC50 (0.26 to 0.29 mg/ml). Both the protein extracts significantly reduced peak blood glucose and area under the curve in Streptozotocin-induced diabetic rats, which were orally challenged with starch and sucrose. CONCLUSIONS: Protein extracts from the fruits of the two varieties of bitter gourd inhibited α-amylase and α-glucosidase in vitro and lowered the blood glucose level in vivo on par with Acarbose when orally administrated to Streptozotocin-induced diabetic rats. Further studies on mechanism of action and methods of safe and biologically active delivery will help to develop an anti-diabetic oral protein drug from these plants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ali, H., Houghton, P. J., & Soumyanath, A. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.004 · Cited by 773
Kar, A., Choudhary, B. K., & Bandyopadhyay, N. G. (2003) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00144-7 · Cited by 591
Lebovitz, H. E. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70266-8 · Cited by 563
?-Glucosidase inhibitors: New complex oligosaccharides of microbial origin
Schmidt, D. D., Frommer, W., Junge, B., M�ller, L., Wingender, W., Truscheit, E., & Sch�fer, D. (1977) · Naturwissenschaften · doi:10.1007/bf00483561 · Cited by 467
The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts
Lordan, S., Smyth, T. J., Soler-Vila, A., Stanton, C., & Ross, R. P. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.04.123 · Cited by 439
Etxeberria, U., de la Garza, A. L., Campión, J., Martínez, J. A., & Milagro, F. I. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.664134 · Cited by 395
Subramanian, R., Asmawi, M. Z., & Sadikun, A. (2008) · Acta Biochimica Polonica · doi:10.18388/abp.2008_3087 · Cited by 363
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
Laar, F. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3119 · Cited by 360
A novel α-glucosidase inhibitor from pine bark
Kim, Y.-M., Wang, M.-H., & Rhee, H.-I. (2004) · Carbohydrate Research · doi:10.1016/j.carres.2003.11.005 · Cited by 325
KWON, Y.-I., APOSTOLIDIS, E., & SHETTY, K. (2008) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.2007.00165.x · Cited by 302
Cited by
Bioactive compounds in anti-diabetic plants: from herbal medicine to modern drug discovery
Tran, N., Pham, B., & Le, L. (2020) · Biology · doi:10.3390/biology9090252 · Cited by 553
Papoutsis, K., Zhang, J., Bowyer, M. C., Brunton, N., Gibney, E. R., & Lyng, J. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2020.128119 · Cited by 364
Metadata
- Authors
- Poovitha, S., & Parani, M.
- Venue
- BMC Complementary and Alternative Medicine
- Published
- 2016-07
- Volume
- 16
- Issue
- S1
- Pages
- 185-185
- ISSN
- 1472-6882 (ISSN-L)
- OpenAlex
- W2500484056
- Cited by
- 307
- References
- 26
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). https://app.cochat.ai/papers/10.1186/s12906-016-1085-1
- The paper
- Poovitha, S., & Parani, M. (2016). In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complementary and Alternative Medicine. https://doi.org/10.1186/s12906-016-1085-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.